Product image of Fymskina (Ustekinumab) supplied by GNH India

Fymskina

Active Ingredient:
Ustekinumab
Origin:
EU

Fymskina (Ustekinumab)

Fymskina (Ustekinumab) is a subcutaneous medication used to manage moderate to severe plaque psoriasis. This biologic therapy targets specific proteins to reduce inflammation and improve skin condition.

Manufacturer / TM Owner

Formycon Ag

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Fymskina is primarily used for the treatment of moderate to severe plaque psoriasis in adults who are candidates for phototherapy or systemic therapy. It works by blocking specific proteins involved in the inflammatory process, helping to reduce skin lesions and improve overall skin health. Patients often wonder, 'What is Fymskina used for?' and the answer lies in its ability to manage chronic skin conditions effectively.

Side Effects

  • Common effects of Fymskina may include redness, itching, or swelling at the injection site. Some users might experience headaches, fatigue, or mild upper respiratory infections. These effects are generally mild and temporary, but any persistent or severe symptoms should be discussed with a healthcare provider.

Precautions & Warnings

  • Fymskina should be handled with care, ensuring proper storage and administration as directed. Patients with a history of serious infections or allergies to similar medications should exercise caution. It is important to follow the prescribed guidelines for subcutaneous use to minimize potential risks.

Avoid Interactions

  • Fymskina may interact with other medications, particularly those that affect the immune system. Patients should inform their healthcare provider about all current medications, including over-the-counter drugs and supplements. Alcohol and certain CYP inhibitors might also influence the effectiveness or safety of Fymskina.

Frequently Asked Questions

Fymskina is used to treat moderate to severe plaque psoriasis in adults who are candidates for phototherapy or systemic therapy.

Fymskina is administered via subcutaneous injection, typically self-administered after proper training.

Common side effects include redness, itching, or swelling at the injection site, headaches, fatigue, and mild upper respiratory infections.

Patients should consult their healthcare provider before combining Fymskina with other medications, as interactions may occur.

Individuals with a history of serious infections or allergies to similar medications should exercise caution and consult their healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Ustekinumab

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT